Wolfram Hoetzenecker
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Wagner N, Lenders M, Kühl K, Reinhardt L, Fuchß M, Ring N, Stäger R, Zellweger C, Ebel C, Kimeswenger S, Oellinger A, Amaral T, Forschner A, Leiter U, Klumpp B, Hoetzenecker W, Terheyden P, Mangana J, Loquai C, Cozzio A, Garbe C, Meier F, Eigentler T, Flatz L. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy. Eur J Cancer 2023; 196:113425.
21.11.2023Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
21.11.2023Eur J Cancer 2023; 196:113425
Wagner Nikolaus, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, Fuchß Milena, Ring Natalie, Stäger Ramon, Zellweger Caroline, Ebel Chiara, Kimeswenger Susanne, Oellinger Angela, Amaral Teresa, Forschner Andrea, Leiter Ulrike, Klumpp Bernhard, Hoetzenecker Wolfram, Terheyden Patrick, Mangana Joanna, Loquai Carmen, Cozzio Antonio, Garbe Claus, Meier Friedegund, Eigentler Thomas Kurt, Flatz Lukas
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Wagner N, Schraag A, Klumpp B, Hoetzenecker W, Berking C, Richtig E, Ziemer M, Mangana J, Terheyden P, Loquai C, Nguyen V, Gebhardt C, Meier F, Diem S, Cozzio A, Flatz L, Röcken M, Garbe C, Gassenmaier M, Weide B, Leiter U, Lenders M, Kühl K, Reinhardt L, André F, Dudda M, Ring N, Ebel C, Stäger R, Zellweger C, Lang R, Paar M, Gussek P, Richtig G, Stürmer S, Kimeswenger S, Oellinger A, Forschner A, Eigentler T. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. J Immunother Cancer 2021; 9
01.01.2021Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
01.01.2021J Immunother Cancer 2021; 9
Wagner Nikolaus, Schraag Amadeus, Klumpp Bernhard, Hoetzenecker Wolfram, Berking Carola, Richtig Erika, Ziemer Mirjana, Mangana Johanna, Terheyden Patrick, Loquai Carmen, Nguyen Van Anh, Gebhardt Christoffer, Meier Friedegund, Diem Stefan, Cozzio Antonio, Flatz Lukas, Röcken Martin, Garbe Claus, Gassenmaier Maximilian, Weide Benjamin, Leiter Ulrike, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, André Fiona, Dudda Milena, Ring Natalie, Ebel Chiara, Stäger Ramon, Zellweger Caroline, Lang Roland, Paar Michael, Gussek Philipp, Richtig Georg, Stürmer Suzan H, Kimeswenger Susanne, Oellinger Angela, Forschner Andrea, Eigentler Thomas K
Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients
Pospischil I, Kagerer M, Cozzio A, Angelova-Fischer I, Guenova E, Ballmer-Weber B, Hoetzenecker W. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients. Int Arch Allergy Immunol 2020; 181:783-789.
11.08.2020Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients
11.08.2020Int Arch Allergy Immunol 2020; 181:783-789
Pospischil Isabella Maria, Kagerer Madeleine, Cozzio Antonio, Angelova-Fischer Irena, Guenova Emmanuella, Ballmer-Weber Barbara, Hoetzenecker Wolfram
Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis
Dimitriou F, Cozzio A, Dummer R, French L, Hoetzenecker W, Brüggen M, Kimeswenger S, Nair G, Schanz U, Guenova E. Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis. Front Med (Lausanne) 2020; 7:290.
25.06.2020Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis
25.06.2020Front Med (Lausanne) 2020; 7:290
Dimitriou Florentia, Cozzio Antonio, Dummer Reinhard, French Lars E, Hoetzenecker Wolfram, Brüggen Marie-Charlotte, Kimeswenger Susanne, Nair Gayathri, Schanz Urs, Guenova Emmanuella
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Saulite I, Bobrowicz M, Hoetzenecker W, Pascolo S, Scarisbrick J, Dummer R, Cozzio A, Nägeli M, Anzengruber F, Varypataki E, Dimitriou F, Fassnacht C, Chang Y, Desislava I, Guenova E. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. Oncoimmunology 2020; 9:1738797.
18.03.2020Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
18.03.2020Oncoimmunology 2020; 9:1738797
Saulite Ieva, Bobrowicz Malgorzata, Hoetzenecker Wolfram, Pascolo Steve, Scarisbrick Julia, Dummer Reinhard, Cozzio Antonio, Nägeli Mirjam, Anzengruber Florian, Varypataki Eleni, Dimitriou Florentia, Fassnacht Christina, Chang Yun-Tsan, Desislava Ignatova, Guenova Emmanuella
Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn
Higgins R, Fischer T, Schwieger-Briel A, French L, Hoetzenecker W, Hornung R, Malzacher A, Cozzio A, Navarini A, Has C, Chang Y, Desislava I, Jensen A, Wachstein J, Bruckner-Tuderman L, Spiegel R, Traber H, Achermann J, Schaller M, Fehrenbacher B, Röcken M, Guenova E. Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn. Acta Derm Venereol 2020; 100:adv00041.
30.01.2020Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn
30.01.2020Acta Derm Venereol 2020; 100:adv00041
Higgins Rebecca, Fischer Tina, Schwieger-Briel Agnes E, French Lars E, Hoetzenecker Wolfram, Hornung René, Malzacher Andreas, Cozzio Antonio, Navarini Alexander, Has Cristina, Chang Yun-Tsan, Desislava Ignatova, Jensen Annika N, Wachstein Julian, Bruckner-Tuderman Leena, Spiegel Roland, Traber Hubert, Achermann Josef, Schaller Martin, Fehrenbacher Birgit, Röcken Martin, Guenova Emmanuella
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
Brüggen M, French L, Hoetzenecker W, Cozzio A, Dummer R, Desislava I, Chang Y, Schanz U, Haralambieva E, Kerl K, Guenova E. Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study. Acta Derm Venereol 2018; 98:835-841.
10.10.2018Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
10.10.2018Acta Derm Venereol 2018; 98:835-841
Brüggen Marie-Charlotte, French Lars E, Hoetzenecker Wolfram, Cozzio Antonio, Dummer Reinhard, Desislava Ignatova, Chang Yun-Tsan, Schanz Urs, Haralambieva Eugenia, Kerl Katrin, Guenova Emmanuella
Pseudolymphomatous Reaction to Red Tattoo Pigment
Saulite I, Pekar-Lukacs A, Kerl K, Cozzio A, Hoetzenecker W, Guenova E. Pseudolymphomatous Reaction to Red Tattoo Pigment. Case Rep Dermatol 2018; 10:162-168.
14.06.2018Pseudolymphomatous Reaction to Red Tattoo Pigment
14.06.2018Case Rep Dermatol 2018; 10:162-168
Saulite Ieva, Pekar-Lukacs Agnes, Kerl Katrin, Cozzio Antonio, Hoetzenecker Wolfram, Guenova Emmanuella
Toxic epidermal necrolysis
Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E, Cozzio A, French L. Toxic epidermal necrolysis. F1000Res 2016; 5
20.05.2016Toxic epidermal necrolysis
20.05.2016F1000Res 2016; 5
Hoetzenecker Wolfram, Mehra Tarun, Saulite Ieva, Glatz Martin, Schmid-Grendelmeier Peter, Guenova Emmanuella, Cozzio Antonio, French Lars E
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets. Biomed Res Int 2016; 2016:9717530.
17.05.2016Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
17.05.2016Biomed Res Int 2016; 2016:9717530
Saulite Ieva, Hoetzenecker Wolfram, Weidinger Stephan, Cozzio Antonio, Guenova Emmanuella, Wehkamp Ulrike
Expression of CD164 on Malignant T cells in Sézary Syndrome
Guenova E, Hoetzenecker W, French L, Kazakov D, Dummer R, Mitev V, Navarini A, Saulite I, Mehra T, Contassot E, Chang Y, Desislava I, Cozzio A. Expression of CD164 on Malignant T cells in Sézary Syndrome. Acta Derm Venereol 2016; 96:464-7.
01.05.2016Expression of CD164 on Malignant T cells in Sézary Syndrome
01.05.2016Acta Derm Venereol 2016; 96:464-7
Guenova Emmanuella, Hoetzenecker Wolfram, French Lars E, Kazakov Dmitry V, Dummer Reinhard, Mitev Vanyo, Navarini Alexander A, Saulite Ieva, Mehra Tarun, Contassot Emmanuel, Chang Yun-Tsan, Desislava Ignatova, Cozzio Antonio
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
Sönnichsen A, Cozzio A, Hoetzenecker W, Schmid-Grendelmeier P, Petrausch U, Chang Y, Desislava I, Mehra T, Kerl K, Mangana J, Saulite I, Guenova E. Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome. J Dermatolog Treat 2016; 27:436-8.
10.02.2016Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
10.02.2016J Dermatolog Treat 2016; 27:436-8
Sönnichsen Astrid, Cozzio Antonio, Hoetzenecker Wolfram, Schmid-Grendelmeier Peter, Petrausch Ulf, Chang Yun-Tsan, Desislava Ignatova, Mehra Tarun, Kerl Katrin, Mangana Johanna, Saulite Ieva, Guenova Emmanuella
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Kleffel S, Hoetzenecker W, Cozzio A, Dummer R, Mihm M, Flaherty K, Frank M, Murphy G, Sharpe A, Kupper T, Thomi R, Lian C, Posch C, Barthel S, Mueller H, Schlapbach C, Guenova E, Elco C, Lee N, Juneja V, Zhan Q, Schatton T. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth. Cell 2015; 162:1242-56.
10.09.2015Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
10.09.2015Cell 2015; 162:1242-56
Kleffel Sonja, Hoetzenecker Wolfram, Cozzio Antonio, Dummer Reinhard, Mihm Martin C, Flaherty Keith T, Frank Markus H, Murphy George F, Sharpe Arlene H, Kupper Thomas S, Thomi Rahel, Lian Christine G, Posch Christian, Barthel Steven R, Mueller Hansgeorg, Schlapbach Christoph, Guenova Emmanuella, Elco Christopher P, Lee Nayoung, Juneja Vikram R, Zhan Qian, Schatton Tobias
Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland
Mehra T, Hoetzenecker W, Moos R, Volbracht J, Guenova E, French L, Hafner J. Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland. Dermatology (Basel) 2015; 231:260-8.
19.08.2015Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland
19.08.2015Dermatology (Basel) 2015; 231:260-8
Mehra Tarun, Hoetzenecker Wolfram, Moos Rudolf, Volbracht Joerk, Guenova Emmanuella, French Lars E, Hafner Jürg
The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis
Bentele-Jaberg N, Guenova E, Mehra T, Nägeli M, Chang Y, Cozzio A, French L, Hoetzenecker W. The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis. Dermatology (Basel) 2015; 231:99-102.
01.07.2015The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis
01.07.2015Dermatology (Basel) 2015; 231:99-102
Bentele-Jaberg Nicoletta, Guenova Emmanuella, Mehra Tarun, Nägeli Mirjam, Chang Yung-Tsan, Cozzio Antonio, French Lars E, Hoetzenecker Wolfram
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
Guenova E, Kaesler S, Thomas P, Mailhammer R, Ghoreschi K, Schäkel K, Amarov B, Eichner M, Schaller M, Clark R, Röcken M, Köberle M, Volz T, Levesque M, Skabytska Y, Hoetzenecker W, Weindl G, Sauer K, Tham M, Kim K, Park J, Seo J, Desislava I, Cozzio A, Biedermann T. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc Natl Acad Sci USA 2015; 112:2163-8.
02.02.2015IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
02.02.2015Proc Natl Acad Sci USA 2015; 112:2163-8
Guenova Emmanuella, Kaesler Susanne, Thomas Peter, Mailhammer Reinhard, Ghoreschi Kamran, Schäkel Knut, Amarov Boyko, Eichner Martin, Schaller Martin, Clark Rachael A, Röcken Martin, Köberle Martin, Volz Thomas, Levesque Mitchell P, Skabytska Yuliya, Hoetzenecker Wolfram, Weindl Günther, Sauer Karin, Tham Manuela, Kim Kyu-Won, Park Ji-Hyeon, Seo Ji Hae, Desislava Ignatova, Cozzio Antonio, Biedermann Tilo
Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome
Mehra T, Guenova E, French L, Dummer R, Hoetzenecker W, Haralambieva E, Schanz U, Nair G, Benz R, Moos R, Ikenberg K, Cozzio A. Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome. JAMA Dermatol 2015; 151:73-7.
01.01.2015Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome
01.01.2015JAMA Dermatol 2015; 151:73-7
Mehra Tarun, Guenova Emmanuella, French Lars Einar, Dummer Reinhard, Hoetzenecker Wolfram, Haralambieva Eugenia, Schanz Urs, Nair Gayathri, Benz Rudolf, Moos Rudolf Maria, Ikenberg Kristian, Cozzio Antonio
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Guenova E, Hoetzenecker W, Rozati S, Levesque M, Dummer R, Cozzio A. Novel therapies for cutaneous T-cell lymphoma: what does the future hold?. Expert Opin Investig Drugs 2014; 23:457-67.
08.01.2014Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
08.01.2014Expert Opin Investig Drugs 2014; 23:457-67
Guenova Emmanuella, Hoetzenecker Wolfram, Rozati Sima, Levesque Mitchell P, Dummer Reinhard, Cozzio Antonio
Treatment of pyoderma gangrenosum with topical factor XIII
Hoetzenecker W, Guenova E, Mitev V, Schanz S, Ulmer A, Fierlbeck G. Treatment of pyoderma gangrenosum with topical factor XIII. Eur J Dermatol 2013; 23:653-7.
01.09.2013Treatment of pyoderma gangrenosum with topical factor XIII
01.09.2013Eur J Dermatol 2013; 23:653-7
Hoetzenecker Wolfram, Guenova Emmanuella, Mitev Vanyo, Schanz Stefan, Ulmer Anja, Fierlbeck Gerhard
Parental anxiety and concern for children undergoing dermatological surgery
Hoetzenecker W, Guenova E, Krug M, Goetz A, Amarov B, Haefner H, Breuninger H. Parental anxiety and concern for children undergoing dermatological surgery. J Dermatolog Treat 2013; 25:367-70.
05.07.2013Parental anxiety and concern for children undergoing dermatological surgery
05.07.2013J Dermatolog Treat 2013; 25:367-70
Hoetzenecker Wolfram, Guenova Emmanuella, Krug Markus, Goetz Angelika, Amarov Boyko, Haefner Hans-Martin, Breuninger Helmut